...
首页> 外文期刊>Military Medicine: Official Journal of AMSUS, The Society of the Federal Health Agencies >A rare case of acute diffuse alveolar hemorrhage following initiation of amiodarone: A case report
【24h】

A rare case of acute diffuse alveolar hemorrhage following initiation of amiodarone: A case report

机译:胺碘酮启动后罕见的急性弥漫性肺泡出血病例:一例报告

获取原文
获取原文并翻译 | 示例

摘要

Amiodarone is effective for treating ventricular and supraventricular tachyarrhythmias, despite potential side effects which can include injury to the liver, thyroid, cornea, skin, and neuromuscular system. Acute lung toxicity is a known but rare side effect of amiodarone use, most commonly taking the form of an acute or subacute interstitial pneumonitis. Diffuse alveolar hemorrhage is a rare reaction, with few case reports documented in the literature since amiodarone became widely used in the early 1980s. We report the case of a patient who developed severe respiratory failure and diffuse alveolar infiltrates within 72 hours of initiating amiodarone therapy. Postmortem lung histology confirmed the diagnosis of diffuse alveolar hemorrhage. The case presentation and proposed mechanisms of action will be reviewed here.
机译:尽管潜在的副作用可能包括对肝脏,甲状腺,角膜,皮肤和神经肌肉系统的伤害,但胺碘酮仍可有效治疗心室和室上性心律失常。急性肺毒性是胺碘酮使用的已知但罕见的副作用,最常见的是急性或亚急性间质性肺炎。弥漫性肺泡出血是一种罕见的反应,自从胺碘酮在1980年代初期被广泛使用以来,文献中很少有病例报道。我们报道了在开始胺碘酮治疗后72小时内出现严重呼吸衰竭并弥漫性肺泡浸润的患者。死后肺组织学证实了弥漫性肺泡出血的诊断。案件介绍和拟议的行动机制将在这里进行审查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号